Earnings ·
Agilon Health reports Q3 net income of $35M, raises full-year Adjusted EBITDA guidance to $145-$155M
AGLagilon health, inc.
Agilon Health reported third-quarter 2026 net income of $35 million, a significant turnaround from the $110 million loss in the prior year period. Total revenue increased 6% year-over-year to $1.52 billion, driven by higher-than-expected burden of illness performance and improved pricing, despite an 8% decline in total platform membership to 566,000. The company's medical services expense ratio improved sharply to 88.5% from 104.0%, resulting in positive Adjusted EBITDA of $64 million compared to negative $91 million a year ago. Reflecting this operational progress, Agilon raised its full-year 2026 Adjusted EBITDA guidance range to $145-$155 million from the previous $75-$95 million estimate. The company operates in the value-based healthcare sector, partnering with physicians and health systems to manage senior patient care.